Miksztal Andrew 4
4 · DURECT CORP · Filed Jan 10, 2006
Insider Transaction Report
Form 4
DURECT CORPDRRX
Miksztal Andrew
VP Pharmaceutical R&D
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2006-01-06+17,761→ 17,761 totalExercise: $5.27From: 2007-01-06Exp: 2016-01-06→ Common Stock (17,761 underlying) - Award
Incentive Stock Option (right to buy)
2006-01-06+57,239→ 57,239 totalExercise: $5.27From: 2007-01-06Exp: 2016-01-06→ Common Stock (57,239 underlying)
Footnotes (1)
- [F1]NQ/ISO Grants Dated January 6, 2006 combined will vest as follows: 1/4 of the underlying securities will vest on each 12-month anniversary of the Grant Date.